Clinical Trials Logo

Clinical Trial Summary

Treatment of patients with Parkinson's disease using mesenchymal stem cells is a perspective method to influence on the pathogenesis of the disease. At the same time, this is a complex and still insufficiently explored process. Autologous mesenchymal stem cells will be transplanted to 30 patients with Parkinson's disease. The results of the effectiveness of the combined and intravenous routes of mesenchymal stem cells administration on the motor and non-motor symptoms in these patients will be evaluated and compared with the results of control group that received placebo therapy


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04146519
Study type Interventional
Source Belarusian Medical Academy of Post-Graduate Education
Contact Vladimir Ponomarev, PhD
Phone 80172959016
Email professor.ponomarev@gmail.com
Status Recruiting
Phase Phase 2/Phase 3
Start date July 1, 2017
Completion date December 31, 2021